DR. ANDREA DOUGLAS

Vice President, R&D Strategy and External Affairs, CSL Limited

Dr. Andrea Douglas is the Vice President, R&D Strategy and External Affairs at CSL Limited, located at CSL’s headquarters in Parkville, Australia. Andrea oversees the global R&D strategy, product portfolio and R&D investment and prioritisation processes and is responsible for relationships with external stakeholders in the Australian Medical and Translational Research environment. Andrea also leads the Government Affairs Strategy in Australia.

Andrea has held various roles at CSL since 2005, including VP Licensing where she lead the in and out licensing of R&D assets, head of Global R&D Project Management and Program Director, Influenza, where she had oversight of CSL’s Influenza Vaccine activities.

Before joining CSL, Andrea was the CEO of the Gene CRC. She also held a senior research role at WEHI where she studied the molecular genetics of breast cancer.

Andrea has a PhD degree in Forensic Medicine from Monash University. She also holds a Masters degree in Health Administration and is a Graduate of the Australian Institute of Company Directors. She has been a Director of AusBiotech since 2013 and the Baker IDI Heart and Diabetes Institute since 2016.

They shall grow not old, as we that are left grow old: Age shall not weary them, nor the years condemn. At the going down of the sun and in the morning, We will remember them. pic.twitter.com/N7YxjyZ7Ys

About 3 weeks ago from NAWO's Twitter via Hootsuite Inc.